TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
130,120
|
119,144
|
105,244 |
Financial expenses |
107
|
130
|
416 |
Earnings before taxes |
17,944
|
4,120
|
-2,706 |
EBITDA |
16,469
|
4,352
|
-1,598 |
Total assets |
108,228
|
90,653
|
89,179 |
Current assets |
107,980
|
89,959
|
87,898 |
Current liabilities |
25,752
|
27,775
|
27,906 |
Equity capital |
81,005
|
62,421
|
61,037 |
- share capital |
349
|
326
|
336 |
Employees (average) |
27
![]() |
27
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
74.8%
|
68.9%
|
68.4% |
Turnover per employee |
4,819
|
4,413
|
3,395 |
Profit as a percentage of turnover |
13.8%
|
3.5%
|
-2.6% |
Return on assets (ROA) |
16.7%
|
4.7%
|
-2.6% |
Current ratio |
419.3%
|
323.9%
|
315.0% |
Return on equity (ROE) |
22.2%
|
6.6%
|
-4.4% |
Change turnover |
2,521
|
17,063
|
7,904 |
Change turnover % |
2%
|
17%
|
8% |
Chg. No. of employees |
0
|
-4
|
2 |
Chg. No. of employees % |
0%
|
-13%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.